CRUK-PH1/105, NCT01212887: Treated Blood Cells, Cyclophosphamide, Fludarabine Phosphate, and Aldesleukin in Treating Patients With Cancer |
|
|
| Terminated | 1 | 14 | Europe | MFE23 scFv-expressing autologous anti-CEA MFEz T lymphocytes, aldesleukin, cyclophosphamide, fludarabine phosphate, laboratory biomarker analysis, pharmacological study | Cancer Research UK | Breast Cancer, Colorectal Cancer, Gastric Cancer, Lung Cancer, Ovarian Cancer, Pancreatic Cancer, Unspecified Adult Solid Tumor, Protocol Specific | 04/10 | 04/10 | | |
